https://www.selleckchem.com/pr....oducts/calpeptin.htm
Therapeutic elevation of high-density lipoprotein (HDL) is thought to minimize atherogenesis in subjects with dyslipidemia. However, this is not the case in clinical practice. The function of HDL is not determined by its concentration in the plasma but by its specific structural components. We previously identified an index for the prediction of HDL functionality, relative HDL (rHDL) index, and preliminarily explored that dysfunctional HDL (rHDL index value 2) failed to rescue the damage to endothelial progenitor cells (EPCs). To
Like
Comment
Share
